Tocqueville Asset Management L.P. Corcept Therapeutics Inc Transaction History

Tocqueville Asset Management L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $1.1 Million - $1.45 Million	-70,000 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$12.3 - $19.3 $861,000 - $1.35 Million	70,000	70,000 $1.35 Million

311

88.3M

1.07M

973K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.71B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.